aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.824
-0.004 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
0.820
-0.004 (-0.47%)
After-hours: Dec 5, 2025, 7:58 PM EST
aTyr Pharma Stock Forecast
ATYR's stock price has decreased by -75.26% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 8.75, with a low estimate of 1.00 and a high estimate of 17. The average target predicts an increase of 962.02% from the current stock price of 0.82.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +21.37% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $1 | Buy → Hold | Downgrades | $25 → $1 | +21.37% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $1.5 | Buy → Hold | Downgrades | $16 → $1.5 | +82.06% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $9 → $17 | Strong Buy | Maintains | $9 → $17 | +1,963.36% | Aug 22, 2025 |
Financial Forecast
Revenue This Year
112.20K
from 235.00K
Decreased by -52.26%
Revenue Next Year
21.13M
from 112.20K
Increased by 18,728.88%
EPS This Year
-0.84
from -0.86
EPS Next Year
-0.63
from -0.84
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 409,500 | 123.9M | ||||
| Avg | 112,200 | 21.1M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 74.3% | 110,327.8% | ||||
| Avg | -52.3% | 18,728.9% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.74 | -0.37 | ||||
| Avg | -0.84 | -0.63 | ||||
| Low | -0.92 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.